These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23823008)

  • 1. Prolonged Ketamine Effects in Sp4 Hypomorphic Mice: Mimicking Phenotypes of Schizophrenia.
    Ji B; Wang X; Pinto-Duarte A; Kim M; Caldwell S; Young JW; Behrens MM; Sejnowski TJ; Geyer MA; Zhou X
    PLoS One; 2013; 8(6):e66327. PubMed ID: 23823008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced NMDAR1 expression in the Sp4 hypomorphic mouse may contribute to endophenotypes of human psychiatric disorders.
    Zhou X; Nie Z; Roberts A; Zhang D; Sebat J; Malhotra D; Kelsoe JR; Geyer MA
    Hum Mol Genet; 2010 Oct; 19(19):3797-805. PubMed ID: 20634195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine independently modulated power and phase-coupling of theta oscillations in Sp4 hypomorphic mice.
    Wang X; Pinto-Duarte A; Behrens MM; Zhou X; Sejnowski TJ
    PLoS One; 2018; 13(3):e0193446. PubMed ID: 29513708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of Sp4 in Forebrain GABAergic Neurons Rescues Hypersensitivity to Ketamine in Sp4 Hypomorphic Mice.
    Higa KK; Ji B; Buell MR; Risbrough VB; Powell SB; Young JW; Geyer MA; Zhou X
    Int J Neuropsychopharmacol; 2015 Jun; 18(11):pyv063. PubMed ID: 26037489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric Disorders.
    Young JW; Kamenski ME; Higa KK; Light GA; Geyer MA; Zhou X
    Neuropsychopharmacology; 2015 Nov; 40(12):2715-26. PubMed ID: 25907107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factor SP4 is a susceptibility gene for bipolar disorder.
    Zhou X; Tang W; Greenwood TA; Guo S; He L; Geyer MA; Kelsoe JR
    PLoS One; 2009; 4(4):e5196. PubMed ID: 19401786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased SP4 and SP1 transcription factor expression in the postmortem hippocampus of chronic schizophrenia.
    Pinacho R; Valdizán EM; Pilar-Cuellar F; Prades R; Tarragó T; Haro JM; Ferrer I; Ramos B
    J Psychiatr Res; 2014 Nov; 58():189-96. PubMed ID: 25175639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-representation of potential SP4 target genes within schizophrenia-risk genes.
    Zhou X
    Mol Psychiatry; 2022 Feb; 27(2):849-854. PubMed ID: 34750502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor Sp4 regulates expression of nervous wreck 2 to control NMDAR1 levels and dendrite patterning.
    Sun X; Pinacho R; Saia G; Punko D; Meana JJ; Ramos B; Gill G
    Dev Neurobiol; 2015 Jan; 75(1):93-108. PubMed ID: 25045015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex receptor mediation of acute ketamine application on in vitro gamma oscillations in mouse prefrontal cortex: modeling gamma band oscillation abnormalities in schizophrenia.
    McNally JM; McCarley RW; McKenna JT; Yanagawa Y; Brown RE
    Neuroscience; 2011 Dec; 199():51-63. PubMed ID: 22027237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interneuron NMDA Receptor Ablation Induces Hippocampus-Prefrontal Cortex Functional Hypoconnectivity after Adolescence in a Mouse Model of Schizophrenia.
    Alvarez RJ; Pafundo DE; Zold CL; Belforte JE
    J Neurosci; 2020 Apr; 40(16):3304-3317. PubMed ID: 32205341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia.
    Sapkota K; Mao Z; Synowicki P; Lieber D; Liu M; Ikezu T; Gautam V; Monaghan DT
    J Pharmacol Exp Ther; 2016 Mar; 356(3):702-11. PubMed ID: 26675679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor SP4 phosphorylation is altered in the postmortem cerebellum of bipolar disorder and schizophrenia subjects.
    Pinacho R; Saia G; Meana JJ; Gill G; Ramos B
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1650-1660. PubMed ID: 26049820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia-like phenotypes in mice with NMDA receptor ablation in intralaminar thalamic nucleus cells and gene therapy-based reversal in adults.
    Yasuda K; Hayashi Y; Yoshida T; Kashiwagi M; Nakagawa N; Michikawa T; Tanaka M; Ando R; Huang A; Hosoya T; McHugh TJ; Kuwahara M; Itohara S
    Transl Psychiatry; 2017 Feb; 7(2):e1047. PubMed ID: 28244984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine administration during the second postnatal week induces enduring schizophrenia-like behavioral symptoms and reduces parvalbumin expression in the medial prefrontal cortex of adult mice.
    Jeevakumar V; Driskill C; Paine A; Sobhanian M; Vakil H; Morris B; Ramos J; Kroener S
    Behav Brain Res; 2015 Apr; 282():165-75. PubMed ID: 25591475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine.
    Forsyth JK; Bachman P; Mathalon DH; Roach BJ; Ye E; Asarnow RF
    Schizophr Bull; 2017 Sep; 43(5):1123-1133. PubMed ID: 28338977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reviewing the ketamine model for schizophrenia.
    Frohlich J; Van Horn JD
    J Psychopharmacol; 2014 Apr; 28(4):287-302. PubMed ID: 24257811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia.
    Balu DT; Li Y; Takagi S; Presti KT; Ramikie TS; Rook JM; Jones CK; Lindsley CW; Conn PJ; Bolshakov VY; Coyle JT
    Neuropsychopharmacology; 2016 Jul; 41(8):2052-61. PubMed ID: 26741285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia.
    Javitt DC; Zukin SR; Heresco-Levy U; Umbricht D
    Schizophr Bull; 2012 Sep; 38(5):958-66. PubMed ID: 22987851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired postnatal development of hippocampal dentate gyrus in Sp4 null mutant mice.
    Zhou X; Qyang Y; Kelsoe JR; Masliah E; Geyer MA
    Genes Brain Behav; 2007 Apr; 6(3):269-76. PubMed ID: 16899055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.